GEMFIBROZIL for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5 adverse event reports in the FDA FAERS database where GEMFIBROZIL was used for Psoriasis.
Most Reported Side Effects for GEMFIBROZIL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug hypersensitivity | 242 | 22.2% | 1 | 1 |
| Drug ineffective | 77 | 7.1% | 3 | 27 |
| Rhabdomyolysis | 63 | 5.8% | 4 | 50 |
| Fatigue | 60 | 5.5% | 8 | 9 |
| Drug interaction | 59 | 5.4% | 12 | 24 |
| Myalgia | 58 | 5.3% | 7 | 17 |
| Nausea | 54 | 5.0% | 8 | 19 |
| Acute kidney injury | 52 | 4.8% | 2 | 39 |
| Diarrhoea | 43 | 4.0% | 17 | 7 |
| Rash | 41 | 3.8% | 8 | 3 |
| Completed suicide | 40 | 3.7% | 40 | 3 |
| Vomiting | 39 | 3.6% | 17 | 11 |
| Malaise | 38 | 3.5% | 7 | 9 |
| Blood triglycerides increased | 35 | 3.2% | 0 | 0 |
| Hypertriglyceridaemia | 34 | 3.1% | 4 | 31 |
Other Indications for GEMFIBROZIL
Product used for unknown indication (208)
Hypertriglyceridaemia (112)
Hyperlipidaemia (61)
Hypercholesterolaemia (50)
Blood cholesterol increased (48)
Dyslipidaemia (37)
Blood cholesterol abnormal (32)
Blood triglycerides increased (32)
Blood cholesterol (17)
Diffuse large b-cell lymphoma (16)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)